Oncology Practice‘Dawn of a new era’ in the treatment of renal cell carcinomaSeptember 7, 2021Genitourinary CancerRenal Cell Carcinoma
Oncology PracticeAlthough inconclusive, CV safety study of cancer therapy attracts attentionAugust 30, 2021Genitourinary Cancer
Oncology Practice‘Routine’ use of focal therapy for prostate cancer in next 5 yearsAugust 11, 2021Genitourinary Cancer
Oncology PracticeOne in three cancer articles on social media has wrong infoAugust 4, 2021Lung CancerBreast CancerGastrointestinal CancerCNS/Brain CancerHead & Neck/Thyroid CancersGynecologic CancerGenitourinary Cancer
Oncology PracticeBone drugs for prostate cancer may result in survival benefitAugust 4, 2021Genitourinary Cancer
Oncology PracticeThe power and promise of social media in oncologyMay 3, 2021Patient & Survivor CareBreast CancerCNS/Brain CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Oncology PracticeSuccess in LGBTQ+ medicine requires awareness of riskApril 30, 2021Preventive CareGenitourinary CancerGynecologic CancerGastrointestinal Cancer
Oncology PracticeHyperprogression on immunotherapy: When outcomes are much worseApril 30, 2021ImmunotherapyNonmelanoma Skin CancerMelanomaBreast CancerGastroenterologyGastrointestinal CancerGenitourinary Cancer
Oncology PracticeFDA panel votes against 2 cancer indications but backs 4 of 6April 30, 2021ImmunotherapyBreast CancerGenitourinary CancerGastrointestinal CancerPatient & Survivor CareMetastatic Breast Cancer
Oncology PracticeTo stay: Two more cancer indications with ‘dangling approvals’April 29, 2021Genitourinary CancerImmunotherapy
Hematology NewsAHA statement flags CV risk of hormonal cancer therapiesApril 29, 2021Mixed TopicsBreast CancerGenitourinary Cancer
Oncology PracticeIMvigor130: A treasure trove of data for urothelial carcinomaApril 23, 2021Genitourinary Cancer
Oncology PracticePersonalized cancer vaccine shows early promise across tumor typesApril 14, 2021Patient & Survivor CareMultiple MyelomaBreast CancerGenitourinary CancerLymphoma & Plasma Cell DisordersHead & Neck/Thyroid CancersLung Cancer
Oncology PracticeHealthy lifestyle may offset genetic risk in prostate cancerApril 13, 2021Genitourinary CancerProstate Cancer
Oncology PracticeSteroid-refractory pneumonitis from ICIs: Experience at major centersApril 9, 2021Patient & Survivor CareLung CancerNonmelanoma Skin CancerMelanomaGastrointestinal CancerHead & Neck/Thyroid CancersLymphoma & Plasma Cell Disorders
